Biotech by today's price change
How far the share price has moved since the previous close.
Moderna has the lowest figure of the 24 biotech ranked by today's price change, at -2.55%, followed by Amgen (-2.40%) and Neurocrine Biosciences (-1.86%). Figures as of 18 Nov 2026, 16:31 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 24
- Lowest
- Moderna-2.55%
- Median
- -0.16%
- Combined market value
- SAR 3.15T
- Countries
- 5
Market values as of .
All countries▾
All sectors▾
Biotech▾
| # | Company | Today ↑ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | ModernaMRNA · Health Care | -2.55% | SAR 305.9B | SAR 755.96 | 2.55% down | 755% up | ||
| 2 | AmgenAMGN · Health Care | -2.40% | SAR 906.8B | SAR 1,676.43 | 2.40% down | 34% up | ||
| 3 | Neurocrine BiosciencesNBIX · Health Care | -1.86% | SAR 61.8B | SAR 610.81 | 1.86% down | 20% up | ||
| 4 | Revolution MedicinesRVMD · Health Care | -1.23% | SAR 130.4B | SAR 602.75 | 1.23% down | 131% up | ||
| 5 | BioNTechBNTX · Health Care | -0.89% | SAR 78.2B | SAR 315.48 | 0.89% down | 16% down | ||
| 6 | Adaptive BiotechnologiesADPT · Health Care | -0.81% | SAR 17.2B | SAR 106.00 | 0.81% down | 88% up | ||
| 7 | VaxcytePCVX · Health Care | -0.69% | SAR 35B | SAR 221.27 | 0.69% down | 22% up | ||
| 8 | Gilead SciencesGILD · Health Care | -0.48% | SAR 788.3B | SAR 635.59 | 0.48% down | 33% up | ||
| 9 | argenxARGX · Health Care | -0.45% | SAR 222.5B | SAR 3,538.07 | 0.45% down | 4% up | ||
| 10 | Kymera TherapeuticsKYMR · Health Care | -0.44% | SAR 38.7B | SAR 453.83 | 0.44% down | 87% up | ||
| 11 | QiagenQGEN · Health Care | -0.41% | SAR 38.4B | SAR 185.84 | 0.41% down | 12% up | ||
| 12 | BiogenBIIB · Health Care | -0.34% | SAR 138.6B | SAR 937.49 | 0.34% down | 49% up | ||
| 13 | Kodiak SciencesKOD · Health Care | +0.02% | SAR 23.7B | SAR 363.17 | 0.02% up | 396% up | ||
| 14 | Bio-TechneTECH · Health Care | +0.14% | SAR 42.9B | SAR 272.81 | 0.14% up | 26% up | ||
| 15 | ExelixisEXEL · Health Care | +0.96% | SAR 63.3B | SAR 259.42 | 0.96% up | 63% up | ||
| 16 | ImmunovantIMVT · Health Care | +1.08% | SAR 26.1B | SAR 125.92 | 1.08% up | 43% up | ||
| 17 | Halozyme TherapeuticsHALO · Health Care | +1.18% | SAR 41.5B | SAR 364.24 | 1.18% up | 37% up | ||
| 18 | CG OncologyCGON · Health Care | +1.25% | SAR 26.8B | SAR 299.82 | 1.25% up | 85% up | ||
| 19 | Twist BioscienceTWST · Health Care | +3.35% | SAR 29.6B | SAR 434.18 | 3.35% up | 340% up | ||
| 20 | Krystal BiotechKRYS · Health Care | +3.86% | SAR 34.5B | SAR 1,163.04 | 3.86% up | 46% up | ||
| 21 | CRISPR TherapeuticsCRSP · Health Care | +4.16% | SAR 15.2B | SAR 156.87 | 4.16% up | 21% down | ||
| 22 | Scholar Rock HoldingSRRK · Health Care | +4.48% | SAR 21.6B | SAR 176.67 | 4.48% up | 14% up | ||
| 23 | ImmunityBioIBRX · Health Care | +5.59% | SAR 26.4B | SAR 24.79 | 5.59% up | 193% up | ||
| 24 | RepligenRGEN · Health Care | +5.60% | SAR 41.1B | SAR 642.43 | 5.60% up | 5% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Sums are converted from US dollars at today's exchange rate (1 USD = 3.7510 SAR).
Questions and answers
Which biotech have the lowest today's price change?
Moderna (-2.55%), Amgen (-2.40%) and Neurocrine Biosciences (-1.86%) have the lowest today's price change of the 24 biotech ranked here as of 18 Nov 2026, 16:31 UTC.
How many biotech are in this ranking?
24 are ranked by today's price change.
What are these biotech worth together?
The 24 biotech ranked by today's price change have a combined market value of SAR 3.15T as of 18 Nov 2026, 16:31 UTC.
What does ranking by today's price change measure?
How far the share price has moved since the previous close.
Learn how this ranking works
All markets guides →- 52-week high and low: what the range tells you
A stock's 52-week high and low are the highest and lowest prices it reached over the past year. Where today's price sits in that range, from 0% at the low to 100% at the high, shows how the past year has gone. Sources differ on whether they use closing or intraday prices, so the same stock's range can differ slightly.
- Drawdown and recovery: why a 50% fall needs a 100% gain
A drawdown is how far a price has fallen from its previous peak, as a percentage of that peak. Recovery needs a larger gain than the fall, because the gain starts from a smaller base: a 20% drop needs a 25% rise to get back, a 50% drop needs 100%, and a 75% drop needs 300%.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Biotech by today's price change”, data as of 18 November 2026. https://funkfolio.com/companies/category/biotech?by=day-change
Underlying data: Yahoo Finance; SEC EDGAR.